An Exploratory Study of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH) (Placebo-Controlled Double-Blind Study)
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Dec 2017
At a glance
- Drugs MT 3995 (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Therapeutic Use
- Sponsors Mitsubishi Tanabe Pharma Corporation
- 29 Nov 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Mar 2018.
- 08 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 13 Oct 2016 New trial record